Wang D - Search Results

1

Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib.

Zhou L, Hou J, Fu W, Wang D, Yuan Z, Jiang H. Zhou L, et al. Among authors: wang d. Leuk Res. 2008 Nov;32(11):1674-83. doi: 10.1016/j.leukres.2008.03.039. Epub 2008 May 15. Leuk Res. 2008. PMID: 18485479

2

Prognostic factors for the efficacy of thalidomide in the treatment of multiple myeloma: a clinical study of 110 patients in China.

Li Y, Hou J, Wang D, Fu W, Yuan Z, Chen Y, Tao Z. Li Y, et al. Among authors: wang d. Leuk Lymphoma. 2006 Dec;47(12):2593-600. doi: 10.1080/10428190600955753. Leuk Lymphoma. 2006. PMID: 17169804

3

[Effects of arsenic trioxide on cell cycle and expression of cyclin dependent kinase inhibitors of multiple myeloma cells].

Chen YB, Fu WJ, Hou J, Ding SQ, Wang DX, Yuan ZG, Kong XT. Chen YB, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Apr;24(4):193-6. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12864950 Chinese.

4

[Mechanism of arsenic trioxide-induced cytotoxicity on multiple myeloma cells].

Chen YB, Hou J, Fu WJ, Ding SQ, Wang DX, Yuan ZG, Kong XT. Chen YB, et al. Ai Zheng. 2003 Dec;22(12):1276-9. Ai Zheng. 2003. PMID: 14693051 Chinese.

5

[Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines].

Zhou LL, Fu WJ, Yuan ZG, Wang DX, Hou J. Zhou LL, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):84-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18315906 Chinese.

6

[Bortezomib-based combination therapy for relapsed or refractory multiple myeloma].

Yuan ZG, Hou J, Wang DX, Fu WJ, Chen YB, Xi H. Yuan ZG, et al. Zhonghua Nei Ke Za Zhi. 2008 Feb;47(2):102-6. Zhonghua Nei Ke Za Zhi. 2008. PMID: 18683793 Clinical Trial. Chinese.

7

[Study on the relationship of beta-catenin level and sensitivity to Bortezomib of myeloma cell lines].

Zhou LL, Fu WJ, Yuan ZG, Wang DX, Hou J. Zhou LL, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):234-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843976 Chinese.

8

Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma.

Li Y, Hou J, Jiang H, Wang D, Fu W, Yuan Z, Chen Y, Zhou L. Li Y, et al. Among authors: wang d. Haematologica. 2007 Sep;92(9):1246-9. doi: 10.3324/haematol.11319. Epub 2007 Aug 1. Haematologica. 2007. PMID: 17666363 Free article.

9

[Identification of a novel mutation of human blood coagulation FV gene associated with congenital FV deficiency].

Fu WJ, Hou J, Wang DX, Yu RQ. Fu WJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Mar;24(3):119-21. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12697120 Chinese.

10

[Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].

Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J. Tao ZF, et al. Ai Zheng. 2006 Apr;25(4):461-4. Ai Zheng. 2006. PMID: 16613681 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62,729 results

Search Page

Filters